Four-Component Recombinant Protein–Based Vaccine Effectiveness Against Serogroup B Meningococcal Disease in Italy

Outcomes of meningococcal serogroup B disease in children after implementation of routine infant 4CMenB vaccination in England: an active, prospective, national surveillance study

(2023) Anna A Mensah et al.   Lancet Child & Adolescent Health

Evolution of invasive meningococcal disease epidemiology in Europe, 2008 to 2017

(2022) Charles Nuttens et al.   Eurosurveillance

Real-world implementation of 4-component meningococcal serogroup B vaccine (4CMenB): implications for clinical practices

(2022) Woo-Yun Sohn et al.   Expert Review of Vaccines

Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case-control study

(2022) Bing Wang et al.   LANCET INFECTIOUS DISEASES

Timing of meningococcal vaccination with 4CMenB (Bexsero®) in children with invasive meningococcal group B (MenB) disease in England

(2022) Shamez N Ladhani et al.   VACCINE

Molecular typing of group B Neisseria meningitidis’subcapsular antigens directly on biological samples demonstrates epidemiological congruence between culture-positive and -negative cases: A surveillance study of invasive disease over a 13-year period

(2021) Lorenzo Lodi et al.   JOURNAL OF INFECTION

Recent advances in meningococcal B disease prevention: real-world evidence from 4CMenB vaccination

(2021) Federico Martinón-Torres et al.   JOURNAL OF INFECTION

A re-assessment of 4CMenB vaccine effectiveness against serogroup B invasive meningococcal disease in England based on an incidence model

(2021) Lorenzo Argante et al.   BMC INFECTIOUS DISEASES

Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England

(2020) Shamez N. Ladhani et al.   NEW ENGLAND JOURNAL OF MEDICINE

Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia

(2020) Helen S. Marshall et al.   NEW ENGLAND JOURNAL OF MEDICINE

The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination

(2020) Sydel R. Parikh et al.   JOURNAL OF INFECTION

Effectiveness and Impact of the 4CMenB Vaccine against Group B Meningococcal Disease in Two Italian Regions Using Different Vaccination Schedules: A Five-Year Retrospective Observational Study (2014–2018)

(2020) Chiara Azzari et al.   Vaccines

Association of Use of a Meningococcus Group B Vaccine With Group B Invasive Meningococcal Disease Among Children in Portugal

(2020) Fernanda M. P. Rodrigues et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Impact of meningococcal B vaccine on invasive meningococcal disease in adolescents

(2020) Mark McMillan et al.   CLINICAL INFECTIOUS DISEASES

Impact of a mass vaccination campaign against Serogroup B meningococcal disease in the Saguenay-Lac-Saint-Jean region of Quebec four years after its launch

(2019) G. Deceuninck et al.   VACCINE

Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adults

(2019) Federico Martinón-Torres et al.   Human Vaccines & Immunotherapeutics

Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines

(2018) Rodolfo Villena et al.   Human Vaccines & Immunotherapeutics

Vaccine responses in newborns

(2017) Anja Saso et al.   Seminars in Immunopathology

Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study

(2016) Sydel R Parikh et al.   LANCET

Distribution of invasive meningococcal B disease in Italian pediatric population: Implications for vaccination timing

(2013) Chiara Azzari et al.   VACCINE

Invasive meningococcal disease in England and Wales: Implications for the introduction of new vaccines

(2012) Shamez N. Ladhani et al.   VACCINE